Today, we issued our fifth issue brief in our Future of Children’s Health Coverage series. It focuses on how to build upon and improve the Medicaid Drug Rebate Program at both the federal and state levels in order to help state Medicaid programs better address their rising prescription drug costs. This, in turn, would ensure continued […]
Fifth in a series of briefs on the future of children’s health care coverage Introduction Prescription drugs are essential for the health of tens of millions of low-income children enrolled in Medicaid. They not only are part of routine pediatric care but also provide critical treatment and maintenance for chronic conditions such as asthma and […]
This webinar reviews overall drug pricing trends, current beneficiary access protections, effectiveness of Medicaid Drug Rebate Program, and state strategies to address rising Medicaid prescription drug costs while maintaining access to needed drugs.
On June 27, the Centers for Medicare and Medicaid Services partially approved Massachusetts’ Medicaid waiver proposal, but among other provisions, rejected a proposal to impose a “closed formulary” for prescription drugs under which the state could entirely exclude coverage of certain drugs in ways not permitted under current law. Instead, CMS expressed openness to approving […]
MedPage Today By: Joyce Frieden The federal government will stop making risk adjustment payments to health insurers that have sicker-than-average patients, raising the specter of more premium increases by insurers to make up for the shortfall. … Withholding the payments will have both short-term and long-term effects, according to Edwin Park, JD, of Georgetown University. […]
Modern Healthcare By: Virgil Dickson The CMS has denied Massachusetts’ request to become the first state in the nation to determine which drugs it will cover in its Medicaid program. … If states do pursue the demo the CMS described, access to drugs could be harmed as it’s unlikely states will get discounts as deep as […]